The hold doesn't apply to Nash or cancer. Yet, app

Quote:

---

The hold doesn't apply to Nash or cancer. Yet, apparently no clinical trial protocols have been submitted

---

The holds pertained to HIV and Covid because those were the only two ongoing trials we had at the time. Which doesn't mean they won't block any new clinical trial from starting until the hold is lifted.

Quote:

---

it almost sounded as if Cyrus was saying:at this point, we will pass along ANY buyout offer to the shareholders for consideration

---

Cyrus predicated that on whether it was reasonable compared to the potential future earnings from leronlimab. Which is the criteria that should be used in determining whether an offer should be presented to shareholders for a vote. So we will never know about any lowball offers that are made.